FR2669929B1 - - Google Patents

Info

Publication number
FR2669929B1
FR2669929B1 FR9115031A FR9115031A FR2669929B1 FR 2669929 B1 FR2669929 B1 FR 2669929B1 FR 9115031 A FR9115031 A FR 9115031A FR 9115031 A FR9115031 A FR 9115031A FR 2669929 B1 FR2669929 B1 FR 2669929B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9115031A
Other languages
French (fr)
Other versions
FR2669929A1 (fr
Inventor
Allan D Pronovost
Jan W Pawlak
Condon
S Kristy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quidel Corp
Original Assignee
Quidel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quidel Corp filed Critical Quidel Corp
Publication of FR2669929A1 publication Critical patent/FR2669929A1/fr
Application granted granted Critical
Publication of FR2669929B1 publication Critical patent/FR2669929B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
FR9115031A 1990-12-04 1991-12-04 Composition d'antigenes, procede de detection de helicobacter pylori a l'aide de cette composition et necessaire la contenant. Granted FR2669929A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62184590A 1990-12-04 1990-12-04

Publications (2)

Publication Number Publication Date
FR2669929A1 FR2669929A1 (fr) 1992-06-05
FR2669929B1 true FR2669929B1 (en:Method) 1995-05-05

Family

ID=24491888

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9115031A Granted FR2669929A1 (fr) 1990-12-04 1991-12-04 Composition d'antigenes, procede de detection de helicobacter pylori a l'aide de cette composition et necessaire la contenant.

Country Status (5)

Country Link
US (2) US5814455A (en:Method)
JP (1) JP3202772B2 (en:Method)
DE (1) DE4139840B4 (en:Method)
FR (1) FR2669929A1 (en:Method)
IT (1) IT1252164B (en:Method)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
ATE244578T1 (de) * 1993-07-27 2003-07-15 Csl Ltd Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
GB2303855B (en) * 1994-07-01 1998-10-28 Rican Limited Helicobacter pylori antigenic protein preparation and immunoassays
GB9502899D0 (en) * 1995-02-15 1995-04-05 Cortecs Ltd Novel antigen
FR2736360B1 (fr) 1995-07-04 1997-09-05 Pasteur Institut Clonage et caracterisation du gene fiba de h.pylori, production de souches aflagellees
FR2739623B1 (fr) * 1995-10-04 1997-12-05 Pasteur Merieux Serums Vacc Nouvelle proteine membranaire p76 d'helicobacter pylori
FR2739622B1 (fr) * 1995-10-04 1997-12-05 Pasteur Merieux Serums Vacc Nouvelles proteines membranaires d'helicobacter pylori
ATE355375T1 (de) 1996-01-04 2006-03-15 Novartis Vaccines & Diagnostic Bakterioferritin aus helicobacter pylori
NZ333250A (en) * 1996-06-10 2000-05-26 Thomas Boren Helicobacter pylori blood group antigen binding adhesion protein
US6902903B1 (en) * 1996-12-19 2005-06-07 Chiron Corporation Helicobacter pylori diagnostics
MX9703918A (es) 1997-05-28 1998-11-30 J Marshall M D Barry Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
CA2293677C (en) * 1998-04-14 2009-01-27 Otsuka Pharmaceutical Co., Ltd. Method for assay of antibodies and antibody assay device
WO2000056769A2 (en) * 1999-03-18 2000-09-28 Cambridge Life Sciences COMPOSITIONS, TEST KITS AND METHODS FOR DETECTING $i(HELICOBACTER PYLORI)
US6682940B2 (en) 1999-05-04 2004-01-27 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6828157B1 (en) 1999-05-04 2004-12-07 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
FR2803302B1 (fr) * 2000-01-04 2004-12-10 Pf Medicament Procede de preparation d'un polypeptide soluble en solvant aqueux en absence de detergent
US7179609B1 (en) 2000-10-04 2007-02-20 Atrophus Ab Screening method for gastritis
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
US20050266499A1 (en) * 2001-04-25 2005-12-01 Rockeby Biomed Corporation, Ltd. Method and apparatus for testing for presence or absence of select biological substances
RU2196993C1 (ru) * 2001-06-05 2003-01-20 Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера Способ серодиагностики helicobacter pylori-инфекции иммуноферментным анализом
WO2003018054A1 (en) * 2001-08-31 2003-03-06 Chiron Srl. Helicobacter pylori vaccination
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
US7008777B2 (en) * 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
USD485359S1 (en) 2001-10-15 2004-01-13 Kimberly-Clark Worldwide, Inc. Specimen-handling tool
US6929926B2 (en) 2001-10-15 2005-08-16 Barry J. Marshall Composition for the detection of gastrointestinal disorders
USD467348S1 (en) 2001-10-15 2002-12-17 Kimberly-Clark Worldwide, Inc. Diagnostic test carrier
US6890765B2 (en) * 2001-11-02 2005-05-10 Roche Diagnostics Operations, Inc. Particles for immunoassays and methods for treating the same
USD470597S1 (en) 2001-12-17 2003-02-18 Kimberly-Clark Worldwide, Inc. Diagnostic test kit
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
USD471639S1 (en) 2001-12-17 2003-03-11 Kimberly-Clark Worldwide, Inc. Tool for handling a specimen
USD469881S1 (en) 2001-12-17 2003-02-04 Kimberly-Clark Worldwide, Inc. Two-well diagnostic test kit with specimen-handling tool
USD470596S1 (en) 2001-12-17 2003-02-18 Kimberly-Clark Worldwide, Inc. Test kit specimen-handling tool
USD470241S1 (en) 2001-12-17 2003-02-11 Kimberly-Clark Worldwide, Inc. Specimen-handling tool
US6777246B2 (en) 2001-12-18 2004-08-17 Roche Diagnostics Gmbh Tertiary amine compounds for use in immunoassays
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
US20030166027A1 (en) * 2002-02-21 2003-09-04 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
SE0200974D0 (sv) 2002-03-27 2002-03-27 Phagen Ab Screening method for gastritis
JP4933258B2 (ja) 2003-09-22 2012-05-16 クイデル コーポレーション 試料中の複数分析物の検出装置
US7629127B2 (en) * 2005-01-21 2009-12-08 Dexall Biomedical Labs, Inc. Method for the visual detection of specific antibodies by the use of lateral flow assays
CN101351710B (zh) 2005-04-04 2013-06-05 生物基因Idecma公司 评价对治疗性蛋白质的免疫应答的方法和产品
US7713715B2 (en) * 2005-09-06 2010-05-11 University Of Tennessee Research Foundation Method for diagnosing infections
WO2007100770A2 (en) 2006-02-28 2007-09-07 Elan Pharmaceuticals, Inc. Methods of treating inflammatory and autoimmune diseases with natalizumab
BRPI0708392A2 (pt) 2006-03-03 2011-05-24 Elan Pharm Inc métodos de tratamento de um paciente com uma doença inflamatória ou autoimune com natalizumab e de uso de natalizumab para tratar um paciente com uma doença inflamatória ou autoimune
WO2008021954A2 (en) * 2006-08-09 2008-02-21 Biogen Idec Ma Inc. Method for distribution of a drug
US9086408B2 (en) 2007-04-30 2015-07-21 Nexus Dx, Inc. Multianalyte assay
CN101607995B (zh) 2007-06-15 2013-05-01 厦门大学 特异性结合h5亚型禽流感病毒血凝素蛋白的单克隆抗体或其结合活性片段及其用途
US9404911B2 (en) 2008-04-21 2016-08-02 Quidel Corporation Integrated assay device and housing
WO2009149293A1 (en) * 2008-06-04 2009-12-10 Ds Genomics Rapid detection of post-vaccination antibody response
US8692873B2 (en) 2009-01-15 2014-04-08 Alverix, Inc. Video-frame data receiver with low frame capture rate
US8422740B2 (en) 2009-01-15 2013-04-16 Scott Dylewski Methods for determining a liquid front position on a test strip
AU2010303156B2 (en) 2009-10-11 2016-02-04 Biogen Ma Inc. Anti-VLA-4 related assays
US11287423B2 (en) 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
DK2524060T3 (en) 2010-01-11 2018-03-12 Biogen Ma Inc ASSAY FOR JC VIRUS ANTIBODIES
US10295472B2 (en) 2010-05-05 2019-05-21 Alverix, Inc. Assay reader operable to scan a test strip
HUE043339T2 (hu) 2011-05-31 2019-08-28 Biogen Ma Inc Módszer a PML kockázatának megállapítására
CN102305857A (zh) * 2011-08-02 2012-01-04 深圳市亚辉龙生物科技有限公司 一种测定幽门螺杆菌抗体的胶乳免疫试剂及其检测方法
WO2014193804A1 (en) 2013-05-28 2014-12-04 Biogen Idec Ma Inc. Method of assessing risk of pml
FI20145550A7 (fi) * 2014-06-13 2015-12-14 Biohit Oyj Gastriini-17 käyttö biomarkkerina atrofiselle gastriitille ja usealle sen seurauksena kohonneelle riskille
EP3785799B1 (en) 2015-08-06 2023-01-18 Lia Diagnostics, Inc. Manufacturing methods for water dispersible assays
CN106148175A (zh) * 2016-05-18 2016-11-23 北京华安麦科生物技术有限公司 一种用于富集微生物的方法及其应用
US20200172768A1 (en) 2018-12-04 2020-06-04 Adhesives Research, Inc. Disintegrable thin film adhesive barrier
FI20205255A1 (en) * 2020-03-11 2021-09-12 Biohit Oyj Gastrin-17 test for screening for dyspepsia and reflux symptoms, and atrophic gastritis, and related risks
CN118591728A (zh) * 2022-01-25 2024-09-03 学校法人北里研究所 使用菌体可溶化组分的检测猪螺杆菌抗体的方法
WO2023145789A1 (ja) * 2022-01-25 2023-08-03 学校法人北里研究所 全菌体を用いた、ヘリコバクター・スイス抗体の検出法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981685A (en) * 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
US4882271A (en) * 1988-03-10 1989-11-21 Baylor College Of Medicine Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection
AU3054789A (en) * 1988-03-23 1989-10-16 Julie Claire Dent Detection of campylobacter pylori urease antibodies and reagent therefor
DE3809796A1 (de) * 1988-03-23 1989-10-05 Wolfgang Prof Dr Med Bredt Verfahren zum reinigen eines 168 kd-proteins von mycoplasma pneumoniae
GB2223756A (en) * 1988-09-29 1990-04-18 Health Lab Service Board Protein purification process

Also Published As

Publication number Publication date
DE4139840B4 (de) 2005-06-02
JPH05264553A (ja) 1993-10-12
US5814455A (en) 1998-09-29
US5846751A (en) 1998-12-08
ITMI913243A0 (it) 1991-12-04
JP3202772B2 (ja) 2001-08-27
ITMI913243A1 (it) 1993-06-04
FR2669929A1 (fr) 1992-06-05
DE4139840A1 (de) 1992-06-11
IT1252164B (it) 1995-06-05

Similar Documents

Publication Publication Date Title
FR2669929B1 (en:Method)
DE4190037T (en:Method)
FR2658574B1 (en:Method)
DE4190243T (en:Method)
FR2667260B1 (en:Method)
DE4192508T (en:Method)
DE4092353T (en:Method)
DE4191962T1 (en:Method)
DE4092580T (en:Method)
FR2657181B1 (en:Method)
FR2663515B1 (en:Method)
FR2656888B1 (en:Method)
DE4092524T (en:Method)
DE4092446T (en:Method)
EP0505567A4 (en:Method)
JPH0492529U (en:Method)
JPH0421371U (en:Method)
ECSM90472U (en:Method)
IN172895B (en:Method)
ECSM90434U (en:Method)
ECSM90508U (en:Method)
ECSM90400U (en:Method)
ECSM90458U (en:Method)
ECSM90457U (en:Method)
ECSM90496U (en:Method)